These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 49251)

  • 1. Hormonal contraceptives and plasma sex hormone binding globulin.
    Briggs MH
    Contraception; 1975 Aug; 12(2):149-53. PubMed ID: 49251
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Some effects of hormonal contraceptives on the mammary tissue. Influence of duration of use and age os user].
    de Sampaio Junior LF; Stecca J; Neme B
    Matern Infanc (Sao Paulo); 1974; 33(4):509-30. PubMed ID: 4470961
    [No Abstract]   [Full Text] [Related]  

  • 4. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Kluft C
    Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of progestin-estrogen combination and progestational contraceptives on pituitary gonadotropins, gonadal steroids and sex hormone-binding globulin.
    Tafurt CA; Sobrevilla LA; de Estrada R
    Fertil Steril; 1980 Mar; 33(3):261-6. PubMed ID: 6767626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity.
    van Kammen E; Thijssen JH; Rademaker B; Schwarz F
    Contraception; 1975 Jan; 11(1):53-9. PubMed ID: 1116360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
    Odlind V; Weiner E; Victor A; Johansson ED
    Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17alpha ethynyl-estradiol concentrations.
    Elstein M; Morris SE; Groom GV; Jenner DA; Scarisbrick JJ; Cameron EH
    Fertil Steril; 1976 Aug; 27(8):892-9. PubMed ID: 955131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical pharmacology of hormonal contraceptives].
    Hubinont PO; Degueldre M; Delvoye P; L'Hermite M; Robyn C; Vekemans M
    Bull Mem Acad R Med Belg; 1975; 130(7-9):351-67. PubMed ID: 800347
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA; Brenner PF; Kletzky OA; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal content of plasma and endometrium of women taking oral contraceptives.
    Porias H; Carranco-López A; Sojo-Aranda I; González-Martínez R; Cervantes C; Parra A; Cortés-Gallegos V
    Obstet Gynecol; 1978 Dec; 52(6):703-7. PubMed ID: 733138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral conception and uterine size-ultrasonic study.
    Pirroinen O; Rauramo L
    Am J Obstet Gynecol; 1975 Jun; 122(3):349-51. PubMed ID: 1130457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New medicines; potency, selectivity and the pill.
    Bodin MA
    J Int Med Res; 1973; 1(2):141-3. PubMed ID: 4619810
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects on blood lipid and androgen levels of two triphasic oral contraceptives.
    Janaud A; Rouffy J; Upmalis D; Dain MP
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():114-6. PubMed ID: 8260968
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized prospective studies on metabolic effects of oral contraceptives.
    Briggs MH; Briggs M
    Acta Obstet Gynecol Scand Suppl; 1982; 105():25-32. PubMed ID: 6805241
    [No Abstract]   [Full Text] [Related]  

  • 17. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of griseofulvin and oral contraceptives.
    Côté J
    J Am Acad Dermatol; 1990 Jan; 22(1):124-5. PubMed ID: 2298948
    [No Abstract]   [Full Text] [Related]  

  • 19. Sex-hormone-binding globulin.
    Anderson DC
    Clin Endocrinol (Oxf); 1974 Jan; 3(1):69-96. PubMed ID: 4134992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.